Market Access/ News/ News Competition for Neurocrine as Gocovri picks up new Parkinson’s indication Richard Staines Adamas Pharmaceuticals, Gocovri, neurology, Parkinson's, R&D 0 Comment Adamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with Share X Competition for Neurocrine as Gocovri picks up new Parkinson’s indication https://pharmaphorum.com/news/competition-for-neurocrine-as-gocovri-picks-up-new-parkinsons-indication/
Adamas Pharmaceuticals, Gocovri, neurology, Parkinson's, R&D
0 Comment
